Healthcare · Drug Manufacturers General · NYSE
| Market cap | $101.58B |
|---|---|
| Trailing P/E | 10.7 |
| FCF yield | 6.1% |
| Revenue growth (YoY) | +4.1% |
| EPS growth (YoY) | +13.3% |
| FCF/share growth (YoY) | +34.0% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
GSK plc trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Nov 21, 2025 |
| Valerie Hoyle | House | Sell | $1,001 - $15,000 | Oct 10, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Sep 12, 2025 |
| Valerie Hoyle | House | Buy | $1,001 - $15,000 | Sep 12, 2025 |
| Robert B. Aderholt | House | Sell | $1,001 - $15,000 | Sep 10, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Aug 13, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Bruce Westerman | House | Sell | $1,001 - $15,000 | May 12, 2025 |
| Bruce Westerman | House | Buy | $1,001 - $15,000 | Apr 16, 2025 |
| Marjorie Taylor Mrs Greene | House | Buy | $1,001 - $15,000 | Nov 27, 2024 |
| Daniel Goldman | House | Sell | $15,001 - $50,000 | Aug 13, 2023 |